209 hedge funds and large institutions have $1.37B invested in Genmab in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 81 increasing their positions, 67 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

8% less funds holding

Funds holding: 226209 (-17)

20% less capital invested

Capital invested by funds: $1.72B → $1.37B (-$349M)

33% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 48

Holders
209
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.04M
Puts
$7.01M
Net Calls
Net Calls Change

Top Buyers

1 +$50.5M
2 +$43.7M
3 +$35.4M
4
BlackRock
BlackRock
New York
+$19.6M
5
Capital International Investors
Capital International Investors
California
+$11.6M

Top Sellers

1 -$58.1M
2 -$37.4M
3 -$29.3M
4
Artisan Partners
Artisan Partners
Wisconsin
-$20.5M
5
FAM
Fred Alger Management
New York
-$19.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$139M
2
$137M
3
$109M
4
$104M
5
$103M
6
$64.1M
7
$58.4M
8
$52M
9
$43.7M
10
$37.4M
11
$32.6M
12
$30M
13
$28.4M
14
$24.2M
15
$23.5M
16
$21.7M
17
$21.6M
18
$19.5M
19
$19M
20
$18.5M
21
$17.4M
22
$16.4M
23
$14.7M
24
$12M
25
$8.72M